ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VSTM Verastem Inc

10.62
0.00 (0.00%)
Pre Market
Last Updated: 04:09:54
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Verastem Inc VSTM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 10.62 04:09:54
Open Price Low Price High Price Close Price Prev Close
10.62
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
3/18/202407:00BWGlobal Patient Survey Results Reveal Significant Negative..
3/14/202416:05BWVerastem Oncology Reports Fourth Quarter and Full Year 2023..
3/11/202417:07EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
3/11/202407:30BWVerastem Oncology Announces Multiple Oral Presentations at..
3/05/202417:27BWVerastem Oncology Receives Orphan Drug Designation from FDA..
3/05/202416:30BWVerastem Oncology Announces Preclinical Presentations for..
2/08/202416:22EDGAR2Form SC TO-I - Tender offer statement by Issuer
2/02/202409:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/29/202416:01EDGAR2Form 8-K - Current report
1/29/202407:00BWVerastem Oncology Outlines Key 2024 Strategic Priorities and..
1/19/202407:54EDGAR2Form 8-K - Current report
1/18/202416:00BWVerastem Oncology Granted Fast Track Designation for..
1/11/202407:00BWVerastem Oncology to Participate in the B. Riley Securities..
1/09/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202416:02EDGAR2Form 8-K - Current report
1/05/202407:00BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
12/28/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/19/202316:01EDGAR2Form DEF 14A - Other definitive proxy statements
12/18/202307:00BWVerastem Oncology Selects Oral KRAS G12D Inhibitor..
12/13/202307:00BWVerastem Oncology Announces Initiation of a Confirmatory..
12/08/202316:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/21/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
11/13/202307:00BWNew Healthcare Professional Component of Let’s Talk About..
11/08/202317:01EDGAR2Form S-3 - Registration statement under Securities Act of..
11/08/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202316:12BWVerastem Oncology Reports Third Quarter 2023 Financial..
11/07/202307:00BWFirst-Of-Its-Kind, Multi-National Patient Impact Survey..
11/06/202307:00BWVerastem Oncology Announces Efficacy and Safety Data of..
10/27/202316:41EDGAR2Form 8-K - Current report
10/26/202316:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202316:05BWVerastem Oncology Strengthens Executive Leadership Team with..
10/18/202316:50BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
10/14/202312:30BWVerastem Oncology Announces Initial Results of RAMP 203..
10/10/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/06/202307:00BWVerastem Oncology Announces Inducement Grants Under Nasdaq..
9/28/202314:27EDGAR2Form 8-K - Current report
9/28/202314:15BWVerastem Presents Avutometinib and Defactinib Combination..
9/25/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/20/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/20/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202316:08EDGAR2Form 8-K - Current report
9/05/202307:00BWVerastem Oncology to Participate in Upcoming Investor..
8/28/202307:00BWVerastem Oncology Enters Discovery and Development..
8/08/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:05BWVerastem Oncology Reports Second Quarter 2023 Financial..
8/04/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/04/202316:40EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock